Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Itrifal Kishnizi is a traditional Unani polyherbal formulation used primarily to treat chronic cold, catarrh, headache, and dizziness, as well as to support digestive health. It is prepared from a blend of natural ingredients, including coriander (Kishneez Khushk), yellow myrobalan (Halela Zard), black myrobalan (Halela Siyah), Indian black myrobalan (Post Halela Kabuli), belleric myrobalan (Balela), honey, and ghee. The formulation acts as a brain tonic, helps clear the airways to prevent mucus buildup, and improves gastrointestinal function by relieving indigestion and constipation. It is manufactured and marketed by several traditional medicine companies, including Dawakhana Tibbiya College (Aligarh Muslim University), Hamdard Laboratories, and Rex Remedies.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on itrifal kishnizi.